Eric Coldwell
Stock Analyst at Baird
(3.89)
# 646
Out of 5,055 analysts
191
Total ratings
61.11%
Success rate
6.26%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Outperform | $873 → $927 | $842.09 | +10.08% | 18 | Nov 6, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Outperform | $178 → $199 | $167.81 | +18.59% | 15 | Nov 6, 2025 | |
| IQV IQVIA Holdings | Upgrades: Outperform | $224 → $258 | $220.61 | +16.95% | 19 | Oct 29, 2025 | |
| FTRE Fortrea Holdings | Maintains: Outperform | $9 → $14 | $10.40 | +34.62% | 9 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $222 → $224 | $162.29 | +38.02% | 22 | Sep 2, 2025 | |
| DGX Quest Diagnostics | Downgrades: Neutral | $194 | $186.95 | +3.77% | 11 | Aug 25, 2025 | |
| PINC Premier | Maintains: Neutral | $22 → $27 | $28.19 | -4.22% | 9 | Aug 20, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $197 → $203 | $205.37 | -1.15% | 13 | Aug 13, 2025 | |
| OMI Owens & Minor | Maintains: Outperform | $10 → $7 | $2.80 | +150.00% | 19 | Aug 12, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $290 → $302 | $266.89 | +13.16% | 14 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $313 → $490 | $590.39 | -17.00% | 19 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $16 | $9.19 | +74.10% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $57.36 | -21.55% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $77.81 | -15.18% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.36 | +3,282.35% | 4 | Nov 10, 2017 |
McKesson
Nov 6, 2025
Maintains: Outperform
Price Target: $873 → $927
Current: $842.09
Upside: +10.08%
Charles River Laboratories International
Nov 6, 2025
Upgrades: Outperform
Price Target: $178 → $199
Current: $167.81
Upside: +18.59%
IQVIA Holdings
Oct 29, 2025
Upgrades: Outperform
Price Target: $224 → $258
Current: $220.61
Upside: +16.95%
Fortrea Holdings
Sep 3, 2025
Maintains: Outperform
Price Target: $9 → $14
Current: $10.40
Upside: +34.62%
ICON Public Limited Company
Sep 2, 2025
Maintains: Outperform
Price Target: $222 → $224
Current: $162.29
Upside: +38.02%
Quest Diagnostics
Aug 25, 2025
Downgrades: Neutral
Price Target: $194
Current: $186.95
Upside: +3.77%
Premier
Aug 20, 2025
Maintains: Neutral
Price Target: $22 → $27
Current: $28.19
Upside: -4.22%
Cardinal Health
Aug 13, 2025
Maintains: Outperform
Price Target: $197 → $203
Current: $205.37
Upside: -1.15%
Owens & Minor
Aug 12, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $2.80
Upside: +150.00%
Labcorp Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $290 → $302
Current: $266.89
Upside: +13.16%
Jul 23, 2025
Maintains: Neutral
Price Target: $313 → $490
Current: $590.39
Upside: -17.00%
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.19
Upside: +74.10%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $57.36
Upside: -21.55%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $77.81
Upside: -15.18%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.36
Upside: +3,282.35%